GNS Healthcare

About GNS Healthcare

Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs in neurodegenerative disorders, oncology, and immunology. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, multiple myeloma, prostate cancer, and pancreatic cancer, with several more in development. Aitia’s partners include six of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.

Website	http://www.aitiabio.com
Employees	51-200 employees View all GNS Healthcare employees
Industry	Biotechnology
Location	561 Windsor St, Somerville, Massachusetts 02143, US
Founded	2000
Keywords	Oncology, Data Analytics, Big Data, Clinical Trial, Drug Discovery, Bioinformatics, Target Discovery, Genomics Data, Digital Twins, Neurodegenerative Disorders, Causal Ai, In Silico Trials, Virtual Patient